相关实验视频

Updated: Jun 23, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

复发性/耐药神经母细胞瘤的I-mIBG疗法:通向未来的古老桥梁

M A De Ioris1, M F Villani2, F Fabozzi1

  • 1Paediatric Haematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

ESMO open
|April 5, 2025
PubMed
概括

-131元-本基黄胺 (I-mIBG) 治疗与梅尔法兰结合,有效降低了复发性/耐药性神经母细胞瘤的瘤负担. 这种治疗方法在 CAR-T 细胞等新型免疫疗法之前有望改善结果.

关键词:
(131) I-mIBG疗法是一种治疗方法.神经母细胞瘤的神经母细胞瘤儿科瘤学 儿科瘤学他们是天文学家.

更多相关视频

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...